In a mouse model of pancreatic cancer, Zhou et al from Shanghai reported that the experimental drug ABT-199 combined with gemcitabine was far more effective than gemcitabine alone, enhancing its chemotherapeutic effects. https://t.co/6h6JckerO3 https://t.
RT @PancreaticCell: Research from Fudan University: BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in #PancreaticCancer In Vit…
Research from Fudan University: BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in #PancreaticCancer In Vitro & In Vivo https://t.co/QhmlUKKnpO
BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo. https://t.co/tVRCfxbkdh https://t.co/PT5y7swvoi
BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo. #lymphoma #lymsm https://t.co/SPYjrEPMUc